MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

2seventy bio, Inc. - Common Stock (NQ:TSVT)

5.000 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.000
Bid (Size) 4.990 (1,322)
Ask (Size) 5.000 (20)
Prev. Close 5.000
Today's Range 5.000 - 5.000
52wk Range 2.290 - 5.010
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
From 2seventy bio, Inc.
Via Business Wire
News headline image
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+68.9%
+68.9%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+25.6%
+25.6%

More News

Read More
News headline image
2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
From 2seventy bio, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 12, 2024 ↗
Via Benzinga
News headline image
2seventy bio Earnings Preview ↗
Via Benzinga
News headline image
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
News headline image
Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
News headline image
Tuesday's session: top gainers and losers ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Crude Oil Gains 1%; Ciena Earnings Top Views ↗
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal ↗
Via Benzinga
News headline image
US Stocks Mixed; Kohl's Shares Plunge After Q4 Results ↗
Via Benzinga
News headline image
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
Via Benzinga
News headline image
Top 3 Health Care Stocks That May Keep You Up At Night In Q1 ↗
Via Benzinga
News headline image
TSVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 2seventy bio, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal' ↗
Via Benzinga
Topics Government
News headline image
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
From 2seventy bio, Inc.
Via Business Wire
News headline image
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
From 2seventy bio, Inc.
Via Business Wire
News headline image
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data ↗
Via Benzinga
News headline image
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
From 2seventy bio, Inc.
Via Business Wire
News headline image
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
From 2seventy bio, Inc.
Via Business Wire

Frequently Asked Questions

Is 2seventy bio, Inc. - Common Stock publicly traded?
Yes, 2seventy bio, Inc. - Common Stock is publicly traded.
What exchange does 2seventy bio, Inc. - Common Stock trade on?
2seventy bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 2seventy bio, Inc. - Common Stock?
The ticker symbol for 2seventy bio, Inc. - Common Stock is TSVT on the Nasdaq Stock Market
What is the current price of 2seventy bio, Inc. - Common Stock?
The current price of 2seventy bio, Inc. - Common Stock is 5.000
When was 2seventy bio, Inc. - Common Stock last traded?
The last trade of 2seventy bio, Inc. - Common Stock was at 05/12/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story